paclitaxel-bearing nanoconjugate (Mayo Clinic)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepaclitaxel-bearing nanoconjugate (Mayo Clinic)
Drug Alias NamePGA-PTX-E-[c2]
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMayo Clinic
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A